Logo Image
News
Global BulletinAll NewsFDA Approval AlertWomen in Oncology
Media
Around the PracticeBetween the LinesFace OffFrom All AnglesMeeting of the MindsOncViewPodcastsShortsTraining AcademyTreatment Algorithms with the Oncology BrothersVideos
Conferences
Publications
All JournalsEditorial BoardFor AuthorsYear in Review
More
Events
Frontline ForumSatellite Sessions
CME/CE
Resources
Awareness MonthThe Bispecifics NetworkNurse Practitioners/Physician's AssistantsPartnersSponsoredSponsored Media
Career Center

Subscribe

  • News
  • Media
  • Conferences
  • Publications
  • Events
  • CME/CE
  • Resources
  • Career Center
  • Subscribe
  • Adverse Effects
  • Artificial Intelligence
  • Brain Cancer
  • Breast Cancer
    • HER2-Positive Breast Cancer
    • Triple-Negative Breast Cancer
  • Gastrointestinal Cancer
    • Colorectal Cancer
    • Esophageal Cancer
    • Pancreatic Cancer
    • Gastric Cancer
    • Liver Cancer
  • Genitourinary Cancers
    • Kidney Cancer
    • Bladder Cancer
    • Prostate Cancer
  • Gynecologic Cancers
    • Endometrial Cancer
    • Ovarian Cancer
    • Cervical Cancer
  • Head & Neck Cancer
  • Hematologic Oncology
    • Multiple Myeloma
    • Myelodysplastic Syndromes
    • Myeloproliferative Neoplasms
  • Infection
    • Vaccines
  • Leukemia
  • Lung Cancer
    • Small Cell Lung Cancer (SCLC)
    • Non-Small Cell Lung Cancer (NSCLC)
  • Lymphoma
  • Neuroendocrine Tumors
  • Oncology
  • Pediatric Cancers
  • Psycho-Oncology
  • Radiation Oncology
  • Sarcoma
  • Screening
  • Skin Cancer & Melanoma
  • Surgery
  • Thyroid Cancer
Spotlight -
Psycho-Oncology|
Artificial Intelligence|
Career Center|
Radiation Oncology|
Surgery
Advertisement

Lorraine Drapek, DNP, FNP-BC, AOCNP

Advertisement

Articles by Lorraine Drapek, DNP, FNP-BC, AOCNP

MGH Program Supports Sexual Health of Women Receiving Pelvic RT for Gastrointestinal and Gynecologic Malignancies

ByLorraine Drapek, DNP, FNP-BC, AOCNP
July 18th 2018

In an interview with Cancer Network, Lorraine Drapek describes a multidisciplinary program at MGH to support vaginal and sexual health post RT for GI and gynecologic malignancies.

Advertisement

Latest Updated Articles

  • MGH Program Supports Sexual Health of Women Receiving Pelvic RT for Gastrointestinal and Gynecologic Malignancies
    MGH Program Supports Sexual Health of Women Receiving Pelvic RT for Gastrointestinal and Gynecologic Malignancies

    July 18th 2018



Advertisement
Advertisement

Trending on CancerNetwork

1

FDA Clears Alpha DaRT Trial to Complete Enrollment in Recurrent GBM

2

Belantamab Mafodotin Regimen Yields Enduring Responses in NDMM

3

Arlo-Cel Produces Deep Responses in Pretreated R/R Multiple Myeloma

4

Brentuximab Vedotin/Chemo Regimens Show Similar Efficacy in 2L Lymphoma

5

FDA Approves Gadoquatrane to Detect CNS and Non-CNS Body Region Lesions

  • About
  • Advertise
  • CureToday.com
  • OncLive.com
  • OncNursingNews.com
  • TargetedOnc.com
  • Editorial
  • Contact
  • Terms and Conditions
  • Privacy
  • Do Not Sell My Personal Information
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

Brand Logo

© 2026 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us